4.7 Review

Natural Products in Cardiovascular Diseases: The Potential of Plants from the Allioideae Subfamily (Ex-Alliaceae Family) and Their Sulphur-Containing Compounds

期刊

PLANTS-BASEL
卷 11, 期 15, 页码 -

出版社

MDPI
DOI: 10.3390/plants11151920

关键词

Allium; Tulbaghia; extracts; sulphur-containing compounds; antiplatelet aggregation; hypertension; diabetes; dyslipidaemia

资金

  1. European Regional Development Fund (ERDF) through the Operational Program for Competitiveness Factors (COMPETE) [CENTRO-01-0145-FEDER-000012-N2323, CENTRO-01-0145-FEDER-032179, CENTRO-010145-FEDER-032414, POCI-01-0145-FEDER-022122, UIDB/04539/2020, UIDP/04539/2020]
  2. European Cooperation in Science and Technology (COST) [CA16225]
  3. Portuguese Foundation for Science and Technology (FCT) [POCI-01-0145-FEDER-032414, SFRH/BD/120692/2016]
  4. FCT
  5. La Caixa Foundation
  6. Fundação para a Ciência e a Tecnologia [SFRH/BD/120692/2016] Funding Source: FCT

向作者/读者索取更多资源

Cardiovascular diseases are a major cause of death globally, and their management often involves lifestyle changes and medication. However, current therapies have low patient compliance due to side effects, leading to the need for more acceptable treatment strategies. Medicinal and aromatic plants, particularly those from the Allium and Tulbaghia genera, have been used in traditional medicine for cardiovascular diseases. This review compiles information on their traditional uses and provides an update on in vitro, in vivo, and clinical studies validating their effectiveness. The role of sulphur-containing compounds and their mechanisms of action are also discussed.
Cardiovascular diseases (CVDs) are the leading cause of mortality worldwide and, together with associated risk factors such as diabetes, hypertension, and dyslipidaemia, greatly impact patients' quality of life and health care systems. This burden can be alleviated by fomenting lifestyle modifications and/or resorting to pharmacological approaches. However, due to several side effects, current therapies show low patient compliance, thus compromising their efficacy and enforcing the need to develop more amenable preventive/therapeutic strategies. In this scenario, medicinal and aromatic plants are a potential source of new effective agents. Specifically, plants from the Allioideae subfamily (formerly Alliaceae family), particularly those from the genus Allium and Tulbaghia, have been extensively used in traditional medicine for the management of several CVDs and associated risk factors, mainly due to the presence of sulphur-containing compounds. Bearing in mind this potential, the present review aims to gather information on traditional uses ascribed to these genera and provide an updated compilation of in vitro and in vivo studies validating these claims as well as clinical trials carried out in the context of CVDs. Furthermore, the effect of isolated sulphur-containing compounds is presented, and whenever possible, the relation between composition and activity and the mechanisms underlying the beneficial effects are pointed out.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据